Company Overview and News
In step with a string of industry closings, and after 70 years in business, Associated Air Center said last month that it will cease operations and close its VIP completion facility on leased property at Dallas Love Field at the end of this year.
The Aviation Industry Corporation of China (AVIC) is looking to invest in the Philippines, the Board of Investments (BOI) in Manila has revealed.
Avic International Holdings, an electronics manufacturing unit of state-owned aerospace giant Aviation Industry Corp of China, says its mainland-listed unit has agreed to buy Xiamen Tianma Microelectronics, the country’s largest flat product display supplier, for 10.6 billion yuan (US$1.5 billion).
MANILA, Philippines - Chinese investors have began lining up to invest in the country, with new projects worth at least $10 billion expected to be infused amid improved economic ties between the Philippines and China.
S t a t e - o w n e d C e y l o n Shipping Corporation (CSC) received its latest ship ‘Ceylon Princess’, which arrived at the Colombo Port yesterday. Ceylon Princess, the second ship belonging to CSC, was a creation of China’s AVIC International. The other ship in CSC’s possession is ‘Ceylon Breeze’, which was delivered in March, this year. The two ships, for which orders were placed during the previous administration, are said to have cost US $ 70 million
Hong Kong and Shanghai stocks lost momentum in the morning session Thursday, ending midday flat to slightly lower, as investors pared back their exposure to risky investments following a uninspired performance in overseas markets overnight amid a sharp fall in crude oil prices.
Hong Kong and Shanghai stocks fell on Thursday morning, ending a three-session winning streak, as investors pared back their exposure to risky investments following a flat performance in overseas markets overnight amid a sharp fall in crude oil prices.
State-owned Aviation Industry Corporation of China (AVIC) has completed its acquisition of UK-based aerospace company AIM Altitude, it was announced on 3 June.
The Aviation Industry Corporation of China (AVIC) is moving closer to finalising its acquisition of its first UK-based aerospace company.
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...
2018-05-19 - Asif
Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...
2018-05-17 - Asif
Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...